Aspen Aerogels, Inc. (NYSE:ASPN) Given Average Recommendation of “Buy” by Analysts

Aspen Aerogels, Inc. (NYSE:ASPNGet Free Report) has been given an average rating of “Buy” by the five brokerages that are covering the company, Marketbeat.com reports. Five analysts have rated the stock with a buy recommendation. The average 12-month price objective among brokers that have issued ratings on the stock in the last year is $19.00.

A number of equities analysts have issued reports on the company. TheStreet upgraded Aspen Aerogels from a “d+” rating to a “c-” rating in a research note on Wednesday, March 6th. Roth Mkm started coverage on Aspen Aerogels in a research note on Wednesday, March 6th. They set a “buy” rating and a $22.00 price objective on the stock. HC Wainwright reissued a “buy” rating and issued a $20.00 target price on shares of Aspen Aerogels in a research note on Wednesday, February 14th. Canaccord Genuity Group lifted their price objective on Aspen Aerogels from $13.00 to $17.00 and gave the company a “buy” rating in a research report on Wednesday, December 27th. Finally, Canaccord Genuity Group boosted their price objective on shares of Aspen Aerogels from $13.00 to $17.00 and gave the stock a “buy” rating in a report on Wednesday, December 27th.

Get Our Latest Stock Analysis on Aspen Aerogels

Aspen Aerogels Stock Performance

NYSE ASPN opened at $16.63 on Friday. The company has a quick ratio of 2.91, a current ratio of 3.41 and a debt-to-equity ratio of 0.24. Aspen Aerogels has a twelve month low of $5.32 and a twelve month high of $19.10. The company has a market cap of $1.28 billion, a price-to-earnings ratio of -25.20 and a beta of 2.04. The business’s fifty day moving average is $16.56 and its 200 day moving average is $13.24.

Aspen Aerogels (NYSE:ASPNGet Free Report) last posted its quarterly earnings data on Tuesday, February 13th. The construction company reported ($0.01) earnings per share for the quarter, topping the consensus estimate of ($0.12) by $0.11. Aspen Aerogels had a negative return on equity of 10.47% and a negative net margin of 19.19%. The firm had revenue of $84.22 million during the quarter, compared to analyst estimates of $83.82 million. During the same period last year, the company posted ($0.20) EPS. As a group, sell-side analysts expect that Aspen Aerogels will post -0.24 EPS for the current fiscal year.

Institutional Trading of Aspen Aerogels

Several hedge funds have recently bought and sold shares of the stock. Banque Cantonale Vaudoise lifted its stake in Aspen Aerogels by 37.5% in the 1st quarter. Banque Cantonale Vaudoise now owns 4,593 shares of the construction company’s stock worth $81,000 after purchasing an additional 1,252 shares in the last quarter. Thompson Davis & CO. Inc. lifted its stake in Aspen Aerogels by 14.7% in the 4th quarter. Thompson Davis & CO. Inc. now owns 24,150 shares of the construction company’s stock worth $381,000 after purchasing an additional 3,100 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank raised its position in shares of Aspen Aerogels by 38.5% during the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 12,971 shares of the construction company’s stock valued at $205,000 after buying an additional 3,607 shares in the last quarter. Bouvel Investment Partners LLC raised its position in shares of Aspen Aerogels by 4.3% during the 4th quarter. Bouvel Investment Partners LLC now owns 94,318 shares of the construction company’s stock valued at $1,488,000 after buying an additional 3,929 shares in the last quarter. Finally, Mitsubishi UFJ Kokusai Asset Management Co. Ltd. raised its position in shares of Aspen Aerogels by 7.1% during the 3rd quarter. Mitsubishi UFJ Kokusai Asset Management Co. Ltd. now owns 84,257 shares of the construction company’s stock valued at $725,000 after buying an additional 5,611 shares in the last quarter. Hedge funds and other institutional investors own 97.64% of the company’s stock.

Aspen Aerogels Company Profile

(Get Free Report

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.

Further Reading

Analyst Recommendations for Aspen Aerogels (NYSE:ASPN)

Receive News & Ratings for Aspen Aerogels Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspen Aerogels and related companies with MarketBeat.com's FREE daily email newsletter.